FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Efficacy and Safety From a Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study

Main Article Content

Joseph Raoof
Deirdre Hooper
Angela Moore
Martin Zaiac
Tory Sullivan
Leon Kircik
Edward Lain
Jasmina Jankivevic
Iain Stuart

Keywords

acne, minocycline

Abstract

Abstract not available.

 

Disclosures: Study sponsored by Foamix Pharmaceuticals.

Copyright 2018 SKIN